Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.

Meredith S PelsterStephen K GruschkusRoland BassettDan S GombosMichael ShephardLiberty PosadaMaura S GloverRinata SimienAdi DiabPatrick HwuBrett W CarterSapna Pradyuman Patel

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)

The combination regimen of nivolumab plus ipilimumab demonstrates activity in metastatic uveal melanoma, with deep and sustained confirmed responses.

Keyphrases

phase ii study
squamous cell carcinoma
small cell lung cancer
locally advanced
open label
skin cancer